AI’s Transformative Role in Healthcare: Code of Conduct

By HEOR Staff Writer

April 18, 2024

AI's transformative role in healthcare

Introduction:

Artificial Intelligence (AI) has begun to play a transformative role in healthcare, promising to reshape the industry with improved outcomes and efficiency. The Leverhulme Centre for the Future of Intelligence’s launch event highlighted AI’s potential to be the most significant event in our civilisation, a sentiment echoed by Stephen Hawking. This article examines AI’s burgeoning impact on healthcare and addresses the balance between its benefits and risks.

The Rise of AI in Clinical Applications:

AI’s integration into healthcare is rapidly advancing. It is employed in disease detection, real-time outcome prediction, treatment personalisation, and administrative task streamlining. AI’s capacity to augment human decision-making in these areas is remarkable. For instance, AI models have significantly reduced the drug discovery timeline, a boon for pharmaceutical development.

Navigating the Risks of AI in Healthcare:

Despite the promise of AI, risks such as bias, privacy breaches, and workforce displacement loom large. The datasets and models AI relies on are human creations, subject to human error and prejudice. Recognising and addressing these risks is crucial to prevent exacerbating healthcare inequities and introducing new ones.

Frameworks for Responsible AI Use:

A multitude of frameworks have emerged to guide the responsible use of AI in healthcare. The Asilomar AI Principles, for example, set forth guidelines for AI development and usage. However, the rapid evolution of AI technologies, such as large language models, presents challenges to the practical application of these frameworks, highlighting the need for adaptive governance.

Towards a Harmonised AI Code of Conduct:

A proposed AI Code of Conduct aims to harmonise principles and commitments for stakeholders across the AI lifecycle. This framework builds on the core principles of a continuously learning health system (LHS) and reflects a consensus-driven approach to fostering responsible AI use in healthcare.

Conclusion:

AI offers an unprecedented opportunity to realise the vision of a learning health system. However, its application must be managed collectively and responsibly. The proposed AI Code of Conduct provides a foundation for stakeholder engagement and the co-creation of a future where AI-enabled health, healthcare, and biomedical science serve the well-being of all.

Reference url

Recent Posts

Mirvetuximab ovarian cancer
NICE Guidance on Mirvetuximab Ovarian Cancer Treatment

By HEOR Staff Writer

June 5, 2026

Mirvetuximab ovarian cancer treatment has taken a major step forward after NICE recommended mirvetuximab soravtansine for adults with folate receptor-alpha positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who have received one to three...
Immunotherapy for Liver Cancer
Exploring Immunotherapy for Liver Cancer through the EMERALD-3 Trial

By HEOR Staff Writer

June 5, 2026

Immunotherapy for liver cancer has advanced substantially with the EMERALD-3 Phase III trial, which showed that
biosimilar policy development
Multistakeholder Engagement in Biosimilar Policy Development

By João L. Carapinha

June 3, 2026

In advancing biosimilar policy development across Europe, the AUGMENT Biosimilars project identifies effective measures to overcome barriers to uptake, lower costs, and expand patient access to follow-on biological medicines. The three-day